id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-E-3535-0006,FDA,FDA-2024-E-3535,Determination of Regulatory Review Period for Purposes of Patent Extension; AURORA EV–ICD,Notice,Determinations,2026-02-06T05:00:00Z,2026,2,2026-02-06T05:00:00Z,,2026-02-06T20:29:21Z,2026-02383,0,0,09000064b9196229